296 related articles for article (PubMed ID: 7618426)
41. Fluid resuscitation in circulatory shock.
Imm A; Carlson RW
Crit Care Clin; 1993 Apr; 9(2):313-33. PubMed ID: 8490765
[TBL] [Abstract][Full Text] [Related]
42. Albumin is a blood product too - is it safe for all patients?
Myburgh JA; Finfer S
Crit Care Resusc; 2009 Mar; 11(1):67-70. PubMed ID: 19281447
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic plasma exchange in a single center: Ibni Sina experience.
Arslan O; Arat M; Tek I; Ayyildiz E; Ilhan O
Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
[TBL] [Abstract][Full Text] [Related]
44. Safety of plasma volume expanders.
Farrugia A
J Clin Pharmacol; 2011 Mar; 51(3):292-300. PubMed ID: 20501941
[TBL] [Abstract][Full Text] [Related]
45. The importance of colloid osmotic pressure measurements to prevent oncotic overdosage during cardiac surgery.
Bartels C; Hadzik B; Abel M; Roth B; Diefenbach C; De Vivie R
J Cardiovasc Surg (Torino); 1995 Oct; 36(5):417-22. PubMed ID: 8522554
[TBL] [Abstract][Full Text] [Related]
46. Fluid resuscitation of hypovolemia.
Sturm JA; Wisner DH
Intensive Care Med; 1985; 11(5):227-30. PubMed ID: 3905899
[No Abstract] [Full Text] [Related]
47. Why do intensivists still use hydroxyethyl starch?
Kellum JA; James MF
Crit Care Med; 2010 Nov; 38(11):2260-2. PubMed ID: 20959756
[No Abstract] [Full Text] [Related]
48. Rationale for albumin infusions.
Soeters PB
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):258-64. PubMed ID: 19337124
[TBL] [Abstract][Full Text] [Related]
49. Clinical indications for the albumin use: still a controversial issue.
Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
[TBL] [Abstract][Full Text] [Related]
50. Clinical indications for human serum albumin.
Lundsgaard-Hansen P; Pappova E; Frei E
Dev Biol Stand; 1980; 48():69-74. PubMed ID: 7274567
[TBL] [Abstract][Full Text] [Related]
51. Albumin and colloid osmotic pressure implications for fluid resuscitation.
Kaminski MV; Haase TJ
Crit Care Clin; 1992 Apr; 8(2):311-21. PubMed ID: 1568142
[TBL] [Abstract][Full Text] [Related]
52. Albumin: role and discriminative use in surgery.
Lewis RT
Can J Surg; 1980 Jul; 23(4):322-8. PubMed ID: 6998548
[TBL] [Abstract][Full Text] [Related]
53. [The substitution effect of human albumin in postoperative aseptic and septic disease courses].
Dressler C; Dauberschmidt R
Anaesthesiol Reanim; 1990; 15(6):351-7. PubMed ID: 2083003
[TBL] [Abstract][Full Text] [Related]
54. The Colloid Controversy: Are Colloids Bad and What Are the Options?
Wong C; Koenig A
Vet Clin North Am Small Anim Pract; 2017 Mar; 47(2):411-421. PubMed ID: 27914756
[TBL] [Abstract][Full Text] [Related]
55. [Indications and limitations for colloids in interventions and surgery].
Artmann T; Gan TJ; Kranke P
Med Klin Intensivmed Notfmed; 2015 Apr; 110(2):122-6. PubMed ID: 25801375
[TBL] [Abstract][Full Text] [Related]
56. Colloid versus crystalloid fluid therapy in surgical patients.
Arunachalam L; MacFie J
Br J Surg; 2015 Feb; 102(3):145-7. PubMed ID: 25533178
[No Abstract] [Full Text] [Related]
57. Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients.
Vercueil A; Grocott MP; Mythen MG
Transfus Med Rev; 2005 Apr; 19(2):93-109. PubMed ID: 15852239
[TBL] [Abstract][Full Text] [Related]
58. Component therapy of surgical hemorrhage: red cells, plasma substitutes and albumin.
Lundsgaard-Hansen P; Pappova E
Ann Clin Res; 1981; 13 Suppl 33():26-38. PubMed ID: 7342841
[No Abstract] [Full Text] [Related]
59. Colloids in sepsis: evenly distributed molecules surrounded by uneven questions.
Zampieri FG; Park M; Azevedo LC
Shock; 2013 May; 39 Suppl 1():42-9. PubMed ID: 23481502
[TBL] [Abstract][Full Text] [Related]
60. [Strategies for using albumin].
Laubenthal H
Beitr Infusionsther; 1989; 24():102-11. PubMed ID: 2481527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
